Marlène Malbos, Gabriella Vera, Harsh Sheth, Rhonda E. Schnur, Aurélien Juven, Anne-Claire Brehin, Jayesh Sheth, Ajit Gandhi, Faye L. Shapiro, Ange-Line Bruel, Florent Marguet, Amber Begtrup, Kristin G. Monaghan, Hana Safraou, Marie Brasseur-Daudruy, Frédéric Tran Mau-Them, Yannis Duffourd, Laurence Faivre, Christel Thauvin-Robinet, Paul J. Benke, Christophe Philippe
{"title":"SCYL2-related autosomal recessive neurodevelopmental disorders: Arthrogryposis multiplex congenita-4 and beyond?","authors":"Marlène Malbos, Gabriella Vera, Harsh Sheth, Rhonda E. Schnur, Aurélien Juven, Anne-Claire Brehin, Jayesh Sheth, Ajit Gandhi, Faye L. Shapiro, Ange-Line Bruel, Florent Marguet, Amber Begtrup, Kristin G. Monaghan, Hana Safraou, Marie Brasseur-Daudruy, Frédéric Tran Mau-Them, Yannis Duffourd, Laurence Faivre, Christel Thauvin-Robinet, Paul J. Benke, Christophe Philippe","doi":"10.1111/cge.14608","DOIUrl":null,"url":null,"abstract":"<p>SCY1-like protein 2 (<i>SCYL2</i>) is a member of the SCY1-like pseudokinase family which regulates secretory protein trafficking. It plays a crucial role in the nervous system by suppressing excitotoxicity in the developing brain. <i>Scyl2</i> knockout mice have excess prenatal mortality and survivors show severe neurological dysfunction. Bi-allelic loss-of-function (LOF) variants in <i>SCYL2</i> were recently associated with arthrogryposis multiplex congenita-4 (AMC4) following the report of 6 individuals from two consanguineous unrelated families. The AMC4 phenotype described included severe arthrogryposis, corpus callosum agenesis, epilepsy and frequently, early death. We describe here two additional similarly affected individuals with AMC4, including one diagnosed in the prenatal period, with bi-allelic LOF variants in <i>SCYL2</i>, and two individuals homozygous for missense variants in the protein kinase domain of <i>SCYL2</i> and presenting with developmental delay only. Our study confirms the association of <i>SCYL2</i> with AMC4 and suggests a milder phenotype can occur, extending the phenotypic spectrum of autosomal recessive <i>SCYL2</i>-related disorders.</p>","PeriodicalId":10354,"journal":{"name":"Clinical Genetics","volume":null,"pages":null},"PeriodicalIF":2.9000,"publicationDate":"2024-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cge.14608","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Genetics","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/cge.14608","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"GENETICS & HEREDITY","Score":null,"Total":0}
引用次数: 0
Abstract
SCY1-like protein 2 (SCYL2) is a member of the SCY1-like pseudokinase family which regulates secretory protein trafficking. It plays a crucial role in the nervous system by suppressing excitotoxicity in the developing brain. Scyl2 knockout mice have excess prenatal mortality and survivors show severe neurological dysfunction. Bi-allelic loss-of-function (LOF) variants in SCYL2 were recently associated with arthrogryposis multiplex congenita-4 (AMC4) following the report of 6 individuals from two consanguineous unrelated families. The AMC4 phenotype described included severe arthrogryposis, corpus callosum agenesis, epilepsy and frequently, early death. We describe here two additional similarly affected individuals with AMC4, including one diagnosed in the prenatal period, with bi-allelic LOF variants in SCYL2, and two individuals homozygous for missense variants in the protein kinase domain of SCYL2 and presenting with developmental delay only. Our study confirms the association of SCYL2 with AMC4 and suggests a milder phenotype can occur, extending the phenotypic spectrum of autosomal recessive SCYL2-related disorders.
期刊介绍:
Clinical Genetics links research to the clinic, translating advances in our understanding of the molecular basis of genetic disease for the practising clinical geneticist. The journal publishes high quality research papers, short reports, reviews and mini-reviews that connect medical genetics research with clinical practice.
Topics of particular interest are:
• Linking genetic variations to disease
• Genome rearrangements and disease
• Epigenetics and disease
• The translation of genotype to phenotype
• Genetics of complex disease
• Management/intervention of genetic diseases
• Novel therapies for genetic diseases
• Developmental biology, as it relates to clinical genetics
• Social science research on the psychological and behavioural aspects of living with or being at risk of genetic disease